Richmond Pharmacology is excited to join the BIO International Convention 2026 in San Diego, USA, on 22–25 June 2026.

Uniting global leaders in biotechnology, this convention serves as a hub for ground breaking research, strategic partnerships, and transformative solutions shaping the future of life sciences.

Representing Richmond Pharmacology at the BIO International Convention 2026:

  • Jörg Taubel, Chief Executive Officer
  • Stephen Wilkinson, Business Development Manager

We look forward to connecting with attendees to discuss Richmond’s expertise in:

  • Innovations in biotechnology and clinical trial design
  • Regulatory pathways for emerging therapies
  • Patient-centric approaches and recruitment strategies
  • Collaboration between academia, industry, and regulators
  • Data-driven solutions for accelerating development

Connect With Us

If you are attending BIO International Convention 2026 and would like to explore partnership or development opportunities email us at:

📧 fasteranswers@richmondpharmacology.com

Latest news

Regulatory Pathways to Success

January 9, 2026
Structured pathways to accelerate development and approval.
Read more

Events

Clinical Trials Innovation Programme

10 - 11 February 2026
Richmond Pharmacology is pleased to attend the Clinical Trials Innovation Programme Conference in Nice, France, 10–11 February 2026.
View event